Sign in to follow
Search Results

0 results for 'Boehringer Ingelheim'

You can use to get even better search results
February 02, 2018 | Corporate Counsel

FTC Nominee Christine Wilson Discloses Her In-House Earnings at Delta

New financial disclosure documents provide insight into the pay and assets of the Delta senior vice president for legal, regulatory and international.
3 minute read
January 26, 2018 | Law.com

Skilled in the Art: These Patent Lawyers Had a Pretty Great Week. Plus Celebs and Copyrights

Notable wins for Ed Reines of Weil, Gotshal & Manges and Santa Monica's Kayvan Noroozi, and Peter Perkowski of L.A.'s Perkowski Legal sues singer and actress Jessica Simpson for infringing the copyright on photos of herself.
6 minute read
January 02, 2018 | Law.com

Skilled in the Art: Is PTAB Asking for 'Oil States' Trouble With Ruling on Sovereign Immunity?

By analogizing IPRs to district court litigation, a Patent Trial and Appeal Board panel led by Chief Judge David Ruschke just undercut its position in its Supreme Court fight for survival.
10 minute read
December 21, 2017 | New Jersey Law Journal

NJ to Get $287K Share of Boehringer's $13.5M Off-Label Marketing Settlement

Boehringer Ingelheim Pharmaceuticals Inc. will pay $13.5 million to settle allegations by attorneys general in all 50 states and the District of Columbia that the company marketed some of its drugs for unapproved uses.
3 minute read
December 20, 2017 | Daily Business Review

Boehringer to Pay $13.5M to Settle States' Off-Label Marketing Claims

Boehringer Ingelheim Pharmaceuticals Inc. will pay $13.5 million to settle allegations by attorneys general in all 50 states and the District of Columbia that the company marketed some of its drugs for unapproved uses.
2 minute read
October 17, 2017 | Corporate Counsel

Boston Scientific Hires Boehringer Ingelheim's Head Litigator as New GC

Medical device company Boston Scientific Corp. has appointed Desiree Ralls-Morrison its new general counsel.
5 minute read
August 02, 2017 | Delaware Law Weekly

AbbVie Files New Infringement Case Over Blockbuster Drug Humira

AbbVie Inc. filed a patent infringement lawsuit Wednesday against German rival Boehringer Ingelheim Pharmaceuticals Inc., the second case in Delaware that seeks to block sales of a less-expensive biosimilar version of Humira, AbbVie's top-selling drug.
3 minute read
July 21, 2017 | National Law Journal

SCOTUS' Game-Changing 'Bristol-Myers' Hasn't Yielded Easy Defense Wins

A U.S. Supreme Court decision widely heralded by defense attorneys as a "game-changer" hasn't exactly dealt them a slam dunk in the courts.
11 minute read
June 12, 2017 | Inside Counsel

ACC Joins Amicus Brief on Case That May 'Undermine' In-House Counsel's Ability to Function

For close to a decade, the Federal Trade Commission has been trying to get its hands on documents from drugmaker Boehringer Ingelheim Pharmaceuticals Inc.,…
3 minute read
June 09, 2017 | Corporate Counsel

ACC Joins Amicus Brief on Case That May 'Undermine' In-House Counsel's Ability to Function

For close to a decade, the Federal Trade Commission has been trying to get its hands on documents from drugmaker Boehringer Ingelheim Pharmaceuticals Inc., resulting in a yearslong dispute over what documents and communications are protected when an in-house counsel is involved.
6 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • Good Legal Technology is Good Business: A Case for Bringing Employment Issues In-House

    Brought to you by LexisNexis®

    Download Now

  • Insights and Strategies for Effective Succession Planning in AM Law 100 Firms

    Brought to you by Gallagher

    Download Now

  • State AI Legislation Is on the Move in 2024

    Brought to you by LexisNexis®

    Download Now

  • 2024 ESI Risk Management & Litigation Readiness Report

    Brought to you by Pagefreezer

    Download Now

NEXT